Alzheimer's disease.

Abstract

Over the last three decades, advances in biochemical pathology and human genetics have illuminated one of the most enigmatic subjects in biomedicine--neurodegeneration. Eponymic diseases of the nervous system such as Alzheimer's, Parkinson's, and Huntington's diseases that were long characterized by mechanistic ignorance have yielded striking progress in our understanding of their molecular underpinnings. A central theme in these and related disorders is the concept that certain normally soluble neuronal proteins can misfold and aggregate into oligomers and amyloid fibrils which can confer profound cytotoxicity. Perhaps the foremost example, both in terms of its societal impact and how far knowledge has moved toward the clinic, is that of Alzheimer's disease (AD). Here, we will review the classical protein lesions of the disorder that have provided a road map to etiology and pathogenesis. We will discuss how elucidating the genotype-to-phenotype relationships of familial forms of Alzheimer's disease has highlighted the importance of the misfolding and altered proteostasis of two otherwise soluble proteins, amyloid β-protein and tau, suggesting mechanism-based therapeutic targets that have led to clinical trials.

• Authors: Dennis J Selkoe
• Journal: Cold Spring Harbor perspectives in biology (Cold Spring Harb Perspect Biol) Vol. 3 Issue 7 (Jul 01 2011) ISSN: 1943-0264 [Electronic] United States
• PMID: 21576255 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Amyloid
• Amyloid beta-Protein Precursor

Topics

• Alzheimer Disease (genetics, metabolism, pathology)
• Amyloid (metabolism)
• Amyloid beta-Protein Precursor (chemistry, genetics)
• Animals
• Disease Models, Animal
• Genetic Association Studies
• Humans
• Mice
• Neurofibrillary Tangles (metabolism, pathology)